XML 28 R11.htm IDEA: XBRL DOCUMENT v3.20.4
Fair Value of Financial Instruments
12 Months Ended
Dec. 31, 2020
Fair Value Disclosures [Abstract]  
Fair Value of Financial Instruments

Note 5. Fair Value of Financial Instruments

The following tables summarize the Company’s financial instruments measured at fair value on a recurring basis (in thousands):

 

 

 

 

 

 

 

Fair Value Measurements At

Reporting Date Using

 

 

 

Total

 

 

Quoted

Prices in

Active

Markets

For

Identical

Assets

(Level 1)

 

 

Significant

Other

Observable

Inputs

(Level 2)

 

 

Significant

Unobservable

Inputs

(Level 3)

 

As of December 31, 2020

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commercial paper

 

$

27,136

 

 

$

 

 

$

27,136

 

 

$

 

Corporate debt securities

 

 

26,506

 

 

 

 

 

 

26,506

 

 

 

 

U.S. government and agency securities

 

 

18,141

 

 

 

 

 

 

18,141

 

 

 

 

Total assets measured at fair value

 

$

71,783

 

 

$

 

 

$

71,783

 

 

$

 

As of December 31, 2019

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commercial paper

 

$

9,694

 

 

$

 

 

$

9,694

 

 

$

 

Corporate debt securities

 

 

24,781

 

 

 

 

 

 

24,781

 

 

 

 

Asset backed securities

 

 

5,508

 

 

 

 

 

 

5,508

 

 

 

 

Total assets measured at fair value

 

$

39,983

 

 

$

 

 

$

39,983

 

 

$

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Preferred stock warrant liability

 

$

184

 

 

$

 

 

$

 

 

$

184

 

 

Upon completion of the Company’s IPO in September 2020, the Series C convertible preferred stock warrant was automatically converted into a warrant to purchase 23,122 shares of common stock. The Company adjusted the carrying value of the Series C convertible preferred stock warrant to reflect its estimated fair value on the IPO date and ceased recognizing any fair value adjustments subsequent to its conversion to a common stock warrant.

The assumptions used in the Black-Scholes option pricing model to determine the fair value of the warrant liability were as follows:

 

 

 

September 15,

2020

(Conversion

Date)

 

 

December 31,

2019

 

Fair value of underlying preferred stock

 

$

13.00

 

 

$

9.79

 

Exercise price

 

$

10.812

 

 

$

10.812

 

Risk-free interest rate

 

 

0.7

%

 

 

1.9

%

Expected volatility

 

 

93.3

%

 

 

80.0

%

Expected term (in years)

 

 

9.0

 

 

 

9.7

 

Expected dividend yield

 

 

 

 

 

 

 

The following table provides a reconciliation of the warrant liability measured at fair value using Level 3 significant unobservable inputs (in thousands):

 

 

 

Warrant

Liability

 

Balance at December 31, 2019

 

$

184

 

Change in fair value of warrant liability

 

 

75

 

Conversion to common stock warrant upon completion of IPO

 

 

(259

)

Balance at December 31, 2020

 

$